Study Data Looks Good For Abbott’s Absorb™ Bioresorbable Vascular Scaffold

Positive long-term results for Abbott’s Absorb™ Bioresorbable Vascular Scaffold (BVS) Trial were presented at the 62nd Annual Scientific Session of the American College of Cardiology (ACC) in San Francisco. Three year results from 101 patients show cardiac event rate comparable with metal stents, but improved vasomotion and late lumen gain.

New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold (via PR Newswire)

— Three-year clinical results for treating clogged vessels in the heart with Absorb presented at American College of Cardiology 2013 — Improvements seen in blood vessel movement and area inside the vessel where the scaffold was placed SAN FRANCISCO, March 11, 2013 /PRNewswire/ — Abbott (NYSE: ABT…

published: March 11, 2013 in: Abbott, Cardio, Clinical Studies/Trials

Most read

Latest

^